Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
The Framework Agreement is awarded for the supply of Glatiramer Acetate Injection in 20 mg and 40 mg presentations to Participating Authorities across NHS.
Scotland.
Supply will be made either directly to hospitals, patients in their own homes, or other designated delivery address, via a manufactured commissioned Home Delivery Service or to a home delivery supplier(s) as directed by the Participating Authorities and/or the Authority.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Mylan | 05460854 | - | 1 lot Glatiramer Acetate Injection excluding a manufacturer commissioned Home Delivery Service | - |
| Teva UK Limited | 00302461 | - | 1 lot Glatiramer Acetate Injection including the provision of a manufacturer commissioned Home Delivery Service. | - |
This procurement was divided into 2 lots, each awarded separately.
| Lot | Value | Awarded To | Status |
|---|---|---|---|
| Lot 2 Glatiramer Acetate Injection excluding a manufacturer commissioned Home Delivery Service | £265,129 initial term | Mylan | complete |
| Lot 1 Glatiramer Acetate Injection including the provision of a manufacturer commissioned Home Delivery Service. | £235,114 initial term | Teva UK Limited | complete |
Government spending data: These suppliers have received £84,876,679 in 181 payments (over £25k) from Department of Health and Social Care, NHS England, Guy's and St Thomas' NHS FT, Maidstone and Tunbridge Wells NHS Trust, BEIS (2010-07-22 to 2026-03-12).